21668-77-9,MFCD00191482
Catalog No.:AA003PUV

21668-77-9 | 1,3-Propanedisulfonic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10g
in stock  
$90.00   $63.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003PUV
Chemical Name:
1,3-Propanedisulfonic acid
CAS Number:
21668-77-9
Molecular Formula:
C3H8O6S2
Molecular Weight:
204.2220
MDL Number:
MFCD00191482
SMILES:
OS(=O)(=O)CCCS(=O)(=O)O
Properties
Properties
 
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
254  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-1.6  

Downstream Synthesis Route
17636-10-1    21668-77-9   
disodium3,3'-dithiodipropanesulfonate 

[1]JournaloftheElectrochemicalSociety,2011,vol.158,p.D178-D186

[1]Locationinpatent:experimentalpartLiu;Lu;Gu;Lu[JournaloftheIranianChemicalSociety,2011,vol.8,#3,p.775-781]

21668-77-9    110-95-2   
N,N,N',N'-tetramethyl-N,N'-bis(3-sulfopropyl)-1,3-propandiyldiammoniumbis(hydrogensulfate) 

[1]ChemicalPapers,2018,vol.72,p.643-649

553-26-4    21668-77-9   
4,4'-bis(3-sulfopropyl)bipyridiniumbis(hydrogensulfate) 

[1]Wang,Bingtong;Zhang,Zongbin;Zhang,Xinyu;Sun,Shixin;Wu,Lin;Xing,Rong[ChemicalPapers,2018,vol.72,#3,p.643-649]

Literature

Title: [New trends in the treatment of amyloidosis].

Journal: Medicina clinica 20120526

Title: Counterion condensation in short cationic peptides: limiting mobilities beyond the Onsager-Fuoss theory.

Journal: Electrophoresis 20120301

Title: Review of eprodisate for the treatment of renal disease in AA amyloidosis.

Journal: International journal of nephrology and renovascular disease 20120101

Title: Preclinical development of siRNA therapeutics for AL amyloidosis.

Journal: Gene therapy 20111201

Title: Renal amyloidosis in children.

Journal: Pediatric nephrology (Berlin, Germany) 20110801

Title: Renal amyloidosis: current views on pathogenesis and impact on diagnosis.

Journal: Contributions to nephrology 20110101

Title: Two cationic metal-organic frameworks based on cadmium and α,ω-alkanedisulfonate anions and their photoluminescent properties.

Journal: Dalton transactions (Cambridge, England : 2003) 20101214

Title: [Amyloidosis in rheumatic diseases].

Journal: Annales Academiae Medicae Stetinensis 20100101

Title: [Diagnostics and therapy of AA amyloidosis].

Journal: Der Pathologe 20090501

Title: Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?

Journal: Expert opinion on pharmacotherapy 20080801

Title: [A new treatment of renal disease in AA amyloidosis...and not only that?].

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20080101

Title: Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.

Journal: BMC neuroscience 20080101

Title: Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure.

Journal: Experimental diabetes research 20080101

Title: Eprodisate slows the progression of renal disease in patients with AA amyloidosis.

Journal: Nature clinical practice. Nephrology 20071101

Title: Eprodisate in AA amyloidosis.

Journal: The New England journal of medicine 20070913

Title: Eprodisate for the treatment of renal disease in AA amyloidosis.

Journal: The New England journal of medicine 20070607

Title: Advances in the treatment of amyloidosis.

Journal: The New England journal of medicine 20070607

Title: Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 20070601

Title: [Multisystemic amyloidosis in 2007].

Journal: La Revue de medecine interne 20070501

Title: Dissimilation of C3-sulfonates.

Journal: Archives of microbiology 20060301

Title: Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.

Journal: Journal of neurochemistry 20020501

Title: Ethanedisulfonate is degraded via sulfoacetaldehyde in Ralstonia sp. strain EDS1.

Journal: Archives of microbiology 20010701

Title: Dember LM, et al. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2349-60.

Title: Manenti L, et al. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach? Expert Opin Pharmacother. 2008 Aug;9(12):2175-80.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 21668-77-9
Tags:21668-77-9 Molecular Formula|21668-77-9 MDL|21668-77-9 SMILES|21668-77-9 1,3-Propanedisulfonic acid
Catalog No.: AA003PUV
21668-77-9,MFCD00191482
21668-77-9 | 1,3-Propanedisulfonic acid
Pack Size: 10g
Purity:
in stock
$90.00 $63.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003PUV
Chemical Name: 1,3-Propanedisulfonic acid
CAS Number: 21668-77-9
Molecular Formula: C3H8O6S2
Molecular Weight: 204.2220
MDL Number: MFCD00191482
SMILES: OS(=O)(=O)CCCS(=O)(=O)O
Properties
Storage: Keep in dry area;Room Temperature;  
Complexity: 254  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -1.6  
Downstream Synthesis Route
17636-10-1    21668-77-9   
disodium3,3'-dithiodipropanesulfonate 

[1]JournaloftheElectrochemicalSociety,2011,vol.158,p.D178-D186

21668-77-9    75-50-3    21865-17-8 

[1]Locationinpatent:experimentalpartLiu;Lu;Gu;Lu[JournaloftheIranianChemicalSociety,2011,vol.8,#3,p.775-781]

21668-77-9    110-95-2   
N,N,N',N'-tetramethyl-N,N'-bis(3-sulfopropyl)-1,3-propandiyldiammoniumbis(hydrogensulfate) 

[1]ChemicalPapers,2018,vol.72,p.643-649

553-26-4    21668-77-9   
4,4'-bis(3-sulfopropyl)bipyridiniumbis(hydrogensulfate) 

[1]Wang,Bingtong;Zhang,Zongbin;Zhang,Xinyu;Sun,Shixin;Wu,Lin;Xing,Rong[ChemicalPapers,2018,vol.72,#3,p.643-649]

Literature fold

Title: [New trends in the treatment of amyloidosis].

Journal: Medicina clinica20120526

Title: Counterion condensation in short cationic peptides: limiting mobilities beyond the Onsager-Fuoss theory.

Journal: Electrophoresis20120301

Title: Review of eprodisate for the treatment of renal disease in AA amyloidosis.

Journal: International journal of nephrology and renovascular disease20120101

Title: Preclinical development of siRNA therapeutics for AL amyloidosis.

Journal: Gene therapy20111201

Title: Renal amyloidosis in children.

Journal: Pediatric nephrology (Berlin, Germany)20110801

Title: Renal amyloidosis: current views on pathogenesis and impact on diagnosis.

Journal: Contributions to nephrology20110101

Title: Two cationic metal-organic frameworks based on cadmium and α,ω-alkanedisulfonate anions and their photoluminescent properties.

Journal: Dalton transactions (Cambridge, England : 2003)20101214

Title: [Amyloidosis in rheumatic diseases].

Journal: Annales Academiae Medicae Stetinensis20100101

Title: [Diagnostics and therapy of AA amyloidosis].

Journal: Der Pathologe20090501

Title: Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?

Journal: Expert opinion on pharmacotherapy20080801

Title: [A new treatment of renal disease in AA amyloidosis...and not only that?].

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia20080101

Title: Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.

Journal: BMC neuroscience20080101

Title: Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure.

Journal: Experimental diabetes research20080101

Title: Eprodisate slows the progression of renal disease in patients with AA amyloidosis.

Journal: Nature clinical practice. Nephrology20071101

Title: Eprodisate in AA amyloidosis.

Journal: The New England journal of medicine20070913

Title: Eprodisate for the treatment of renal disease in AA amyloidosis.

Journal: The New England journal of medicine20070607

Title: Advances in the treatment of amyloidosis.

Journal: The New England journal of medicine20070607

Title: Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis20070601

Title: [Multisystemic amyloidosis in 2007].

Journal: La Revue de medecine interne20070501

Title: Dissimilation of C3-sulfonates.

Journal: Archives of microbiology20060301

Title: Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.

Journal: Journal of neurochemistry20020501

Title: Ethanedisulfonate is degraded via sulfoacetaldehyde in Ralstonia sp. strain EDS1.

Journal: Archives of microbiology20010701

Title: Dember LM, et al. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2349-60.

Title: Manenti L, et al. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach? Expert Opin Pharmacother. 2008 Aug;9(12):2175-80.

Building Blocks More >
1346597-52-1
1346597-52-1
Ethyl 2-(2-methoxy-5-pyrimidinyl)-2-oxoacetate
AA003PYN | MFCD20134207
36821-26-8
36821-26-8
2-Oxo-pyrrolidine-3-carboxylic acid ethyl ester
AA003Q2H | MFCD06796534
25597-16-4
25597-16-4
Ethyl 4,4,4-trifluorocrotonate
AA003Q6M | MFCD00009903
869108-50-9
869108-50-9
Ethyl 5-methyl-1,3,4-thiadiazole-2-carboxylate
AA003QA1 | MFCD03840446
5006-62-2
5006-62-2
Ethyl nipecotate
AA003QDB | MFCD00005991
497-37-0
497-37-0
Exo-norborneol
AA003QHT | MFCD00136051
75708-92-8
75708-92-8
Folic acid dihydrate
AA003QLM | MFCD08273745
721-66-4
721-66-4
2-(2-Aminoacetamido)-3-phenylpropanoic acid
AA003QPX | MFCD00065109
815-24-7
815-24-7
Hexamethylacetone
AA003QTU | MFCD00008845
624-75-9
624-75-9
2-Iodoacetonitrile
AA003QXW | MFCD00001886
Submit
© 2017 AA BLOCKS, INC. All rights reserved.